Navigation Links
Perrigo Reports Record Quarterly Revenue and Earnings and Raises Full Year Adjusted EPS Guidance
Date:5/3/2011

generic of Aldara® and the generic version of Xyzal®, as well as $6 million of increased sales volume in the Company's existing products. Reported operating income was $31 million, an increase of approximately $15 million from last year. The increase was driven largely by new product sales and increased operating expense leverage. Reported operating margin increased 430 basis points from last year to 36.9%.  

For the first nine months of fiscal 2011, net sales for the Rx Pharmaceuticals segment increased 62% from fiscal 2010 to $251 million. Net sales increased due primarily to $72 million in new product sales and an increase of $16 million in sales of existing products.  

On February 22, 2011, the Company announced that it had filed an Abbreviated New Drug Application for calcipotriene 0.005% and betamethasone dipropionate 0.064% ointment, a generic form of Taclonex® Ointment.  

API

The API segment reported third quarter net sales of $41 million compared with $33 million a year ago, an increase of 26%. The increase was due primarily to additional sales of existing products of $8 million and new product sales of $5 million led by European sales of temozolomide. The increase was partially offset by an approximately $4 million decrease in revenues related to the sale of dossier agreements. Reported operating income increased $12 million due to higher margin new product sales, decreased operating expenses and improved financial operating leverage. Reported operating margin increased 2920 basis points to 27.5%, and adjusted operating margin increased 820 basis points to 28.7%.  

For the first nine months of fiscal 2011, net sales increased 18% to approximately $119 million, compared to $101 million in fiscal 2010. Reported operating margin increased 1830 basis points to 26.6% from last year's 8.3%.  

Other

Continuing operations for the Other category, consisting of the Israel Ph
'/>"/>

SOURCE Perrigo Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine technology :

1. Perrigo Announces FDA Final Approval for Minoxidil Foam - Generic Equivalent to Mens Rogaine® Foam
2. Perrigo Company Announces Quarterly Dividend
3. Perrigos PBM Infant Formula Unit Wins Appellate Judgment Versus Mead Johnson
4. Perrigo Partner Teva Receives Final OTC Approval for Sales and Distribution of Fexofenadine HCl 60 mg and 180 mg Tablets
5. Perrigo Announces Conclusion of the FDA Re-Inspection
6. Perrigo Company to Present at the Barclays Capital 2011 Global Health Care Conference
7. Perrigo Announces Arrival of the FDA for Reinspection Related to the Allegan Facility Warning Letter
8. Perrigo Company to Present at the Citi 2011 Global Health Care Conference
9. Perrigo Confirms Filing for Generic Version of Taclonex® Ointment and Announcement of Lawsuit by Leo Pharma
10. Perrigo Enters Into Exclusive Sales and Distribution Agreement With AgaMatrix for Store Brand Blood Glucose Monitoring Products
11. Perrigo Announces Settlement of Rogaine® Foam Patent Litigation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... 27, 2015 Harwood Feffer LLP ( www.hfesq.com ... directors of Aerie Pharmaceuticals, Inc. ("Aerie" or the "Company") ... breached its fiduciary duties to shareholders. On ... announcing results from its first Phase 3 registration trial ... that in the trial, Rhopressa failed to meet its ...
(Date:4/27/2015)... 2015  Eiger BioPharmaceuticals, Incorporated today announced the presentation ... in patients with chronic hepatitis delta viral (HDV) infection. ... at Ankara University Medical School, Turkey ... LOWR HDV - 1 (LOnafarnib With and ... randomized subjects to receive different doses of lonafarnib with ...
(Date:4/27/2015)... N.J. , April 27, 2015  CytoSorbents ... critical care immunotherapy commercializing its CytoSorb® extracorporeal cytokine ... announced the appointment of Dr. Joerg Scheier ... Dr. Scheier is a specialist in intensive ... years of combined experience in treating critically-ill patients ...
Breaking Medicine Technology:Harwood Feffer LLP Announces Investigation of Aerie Pharmaceuticals, Inc. 2Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV) 2Eiger Bio Announces Interim Results of Lonafarnib in Combination with Ritonavir or Pegylated Interferon in Patients Infected with Hepatitis Delta Virus (HDV) 3CytoSorbents Appoints Dr. Joerg Scheier as European Medical Director 2CytoSorbents Appoints Dr. Joerg Scheier as European Medical Director 3CytoSorbents Appoints Dr. Joerg Scheier as European Medical Director 4CytoSorbents Appoints Dr. Joerg Scheier as European Medical Director 5
(Date:4/27/2015)... Humble, TX (PRWEB) April 27, 2015 Sitting ... legs to ache and feel tired, and for those whose ... such as receptionists and taxi cab drivers, or to be ... teachers and hairdressers, the discomfort can be more severe and ... tired, achy leg syndrome. Dr. Madaiah Revana of Northeast Houston ...
(Date:4/27/2015)... Douglas Fitzpatrick not only sells auto, life ... also helps secure homes for animals. On May 9, 2015 ... a booth at the 2015 Fetch A Friend Adopt-a-thon at ... Columbus, Ohio. , “I am very excited to be ... adoptable pets from more than forty different rescues, shelters and ...
(Date:4/27/2015)... Ticket Down is a reputable source ... Valley Music Theatre and the Isleta Amphitheater. ... Mexico area can celebrate because their favorite performer will ... Buffett will be performing alongside legendary performers, Huey Lewis ... during the summer and fall months of 2015 are ...
(Date:4/27/2015)... April 27, 2015 The global ... a lower CAGR in developed countries; however, it ... countries such as China, India and Brazil in ... analyzers market is driven by factors such as ... laboratories, development of high-throughput hemostasis analyzers, developments in ...
(Date:4/27/2015)... Volpara Solutions today announced the ... Society of Breast Imaging’s SBI/ACR Breast Imaging Symposium ... #214). VolparaDensity, the first breast density assessment ... tomosynthesis datasets from multiple manufacturers, is already in ... worldwide. , The latest version of ...
Breaking Medicine News(10 mins):Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 2Health News:Northeast Houston Vein Center Offers Tips on How to Treat Achy Legs 3Health News:Farmers Insurance Agent Douglas Fitzpatrick Ensures Pets Find Homes 2Health News:Cheap Jimmy Buffett Tickets at Alpine Valley Music Theatre in Elkhorn, WI and at Isleta Amphitheater in Albuquerque, NM Now on Sale at TicketDown.com 2Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 2Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 3Health News:Volpara Solutions Releases VolparaDensity 3.1 for Use with Tomosynthesis Systems from Multiple Manufacturers at SBI 2Health News:Volpara Solutions Releases VolparaDensity 3.1 for Use with Tomosynthesis Systems from Multiple Manufacturers at SBI 3
... ... referrals using a proprietary system that automatically matches the right clients with the right ... the lenders while increasing conversions for retailers. , ... Orlando, FL (PRWEB) June 17, 2009 -- The world ...
... Epeius Biotechnologies ( www.epeiusbiotech.com ) announced ... Fast Track designation by the U.S. Food and Drug ... advanced or metastatic pancreatic cancer. The FDA Fast Track ... to facilitate the development and expedite the review of ...
... 17 STAAR Surgical Company (Nasdaq: STAA ), ... ophthalmic products, today announced the completion of a registered direct ... price of $1.88 per share, which was the closing market ... be approximately $8.0 million because the Company did not use ...
... ... Energy Medicine) announces that it is taking sign-ups for this year,s annual subtle energies ... July 1st and is called "Sacred Synthesis: Science with Heart". , ... Denver, CO (PRWEB) June 17, 2009 ...
... ... 4 of Remote Control 4.0. It allows help desk staff to administer and ... makes it easy to find computers With its unique search engine. It can ... obtained from http://www.intelliadmin.com/blog/index.php/2009/06/remote-control-40-beta-rc4-and-usb-disabler-pro/ , ...
... , ... of the Dermatology Center of Plano will be relocating his practice to a brand new state ... new practice under the name, Center for Dermatology and Cosmetic Laser Surgery. , ... (PRWEB) June 17, 2009 -- Dr. Bryan Selkin, the ...
Cached Medicine News:Health News:The Equipment Leasing/Financing World Now Has its First Exclusive Online Referral Service 2Health News:The Equipment Leasing/Financing World Now Has its First Exclusive Online Referral Service 3Health News:Epeius Biotechnologies' Rexin-G Receives FDA Fast Track Designation for the Treatment of Pancreatic Cancer 2Health News:Epeius Biotechnologies' Rexin-G Receives FDA Fast Track Designation for the Treatment of Pancreatic Cancer 3Health News:STAAR Surgical Completes Common Stock Offering 2Health News:STAAR Surgical Completes Common Stock Offering 3Health News:2009 ISSSEEM Conference to Have Deepak Chopra Discuss Bridging Science and Spirit 2Health News:2009 ISSSEEM Conference to Have Deepak Chopra Discuss Bridging Science and Spirit 3Health News:Windows 7 Compatible Remote Desktop Software Released (Beta 4) 2Health News:New State of the Art Dermatology Center in Plano TX 2
This new dedicated VICTOR2 model is for fluorescence and luminescence measurements....
... VICTOR2 V measures ... polarization, luminescence, time-resolved ... absorbance. A red-sensitive ... assay. All technologies ...
... is the modular VICTOR2 ... high density TR-fluorometry, stacker ... The extra high density ... excitation beam for TRF ...
Flexible and sensitive fluorescence/luminescence microplate reader for endpoint and kinetic...
Medicine Products: